$NYSE:BMY

Premier Path Wealth Partners LLC Invests in Bristol-Myers Squibb, Boosting Company’s 4th Quarter Performance
Gallery

Premier Path Wealth Partners LLC Invests in Bristol-Myers Squibb, Boosting Company’s 4th Quarter Performance

☀️Trending News BRISTOL-MYERS ($NYSE:BMY): Bristol-Myers Squibb (BMS) is a leading global biopharmaceutical company that focuses on discovering, developing, and delivering [...]

By GoodWhale|March 27, 2024|Categories: Drug Manufacturers - General|Tags: $NYSE:BMY, Drug Manufacturers - General, NYSE|0 Comments

EU Begins Review of Bristol Myers’ Augtyro Cancer Therapy
Gallery

EU Begins Review of Bristol Myers’ Augtyro Cancer Therapy

🌧️Trending News BRISTOL-MYERS ($NYSE:BMY): Bristol Myers Squibb is a global biopharmaceutical company headquartered in New York City, United States. The [...]

By GoodWhale|January 4, 2024|Categories: Drug Manufacturers - General|Tags: $NYSE:BMY, Drug Manufacturers - General, NYSE|0 Comments

Bristol-myers Squibb Stock Fair Value – Bristol-Myers Squibb Expands Oncology Portfolio with Acquisition of Rayzebio for $4.1B
Gallery

Bristol-myers Squibb Stock Fair Value – Bristol-Myers Squibb Expands Oncology Portfolio with Acquisition of Rayzebio for $4.1B

☀️Trending News BRISTOL-MYERS ($NYSE:BMY): Bristol-Myers Squibb is a global biopharmaceutical company that focuses on developing and delivering innovative medicines to [...]

By GoodWhale|December 27, 2023|Categories: Corporate Action, Drug Manufacturers - General, Intrinsic Value|Tags: $NYSE:BMY, Drug Manufacturers - General, NYSE|0 Comments

Bristol-myers Squibb dividend calculator – Bristol-Myers Squibb: Don’t Miss This Dividend Opportunity!
Gallery

Bristol-myers Squibb dividend calculator – Bristol-Myers Squibb: Don’t Miss This Dividend Opportunity!

☀️Trending News BRISTOL-MYERS ($NYSE:BMY): Bristol-Myers Squibb is an attractive investment opportunity right now, offering investors a dividend that makes it [...]

By GoodWhale|December 20, 2023|Categories: Drug Manufacturers - General|Tags: $NYSE:BMY, Drug Manufacturers - General, NYSE|0 Comments

Bristol-Myers Squibb & SystImmune Strike $8.4B License Deal to Develop Cancer Drug
Gallery

Bristol-Myers Squibb & SystImmune Strike $8.4B License Deal to Develop Cancer Drug

🌧️Trending News BRISTOL-MYERS ($NYSE:BMY): Bristol-Myers Squibb, a cutting-edge biopharmaceutical company based in New York, has recently announced an $8.4 billion [...]

By GoodWhale|December 13, 2023|Categories: Drug Manufacturers - General|Tags: $NYSE:BMY, Drug Manufacturers - General, NYSE|0 Comments

Bristol-myers Squibb Stock Fair Value Calculator – Bristol Myers Squibb Receives Priority Review for Urothelial Cancer Combination Therapy
Gallery

Bristol-myers Squibb Stock Fair Value Calculator – Bristol Myers Squibb Receives Priority Review for Urothelial Cancer Combination Therapy

🌧️Trending News BRISTOL-MYERS ($NYSE:BMY): Bristol-Myers Squibb, a leading biopharmaceutical company headquartered in New York City, has recently been granted a [...]

By GoodWhale|December 11, 2023|Categories: Drug Manufacturers - General, Intrinsic Value|Tags: $NYSE:BMY, Drug Manufacturers - General, NYSE|0 Comments

Discover 5+% Yielding Bargains That Outperform Bristol-Myers Squibb As A Buy
Gallery

Discover 5+% Yielding Bargains That Outperform Bristol-Myers Squibb As A Buy

🌥️Trending News BRISTOL-MYERS ($NYSE:BMY): Bristol-Myers Squibb is a leading biopharmaceutical company with a portfolio of innovative medicines, including oncology treatments, [...]

By GoodWhale|December 10, 2023|Categories: Drug Manufacturers - General|Tags: $NYSE:BMY, Drug Manufacturers - General, NYSE|0 Comments

Bristol-myers Squibb Stock Intrinsic Value – Bristol-Myers Squibb Receives Priority Review for Urothelial Cancer Combination Therapy
Gallery

Bristol-myers Squibb Stock Intrinsic Value – Bristol-Myers Squibb Receives Priority Review for Urothelial Cancer Combination Therapy

🌧️Trending News BRISTOL-MYERS ($NYSE:BMY): Bristol-Myers Squibb, an American biopharmaceutical company, recently received priority review from the U.S. Food and Drug [...]

By GoodWhale|December 7, 2023|Categories: Drug Manufacturers - General, Intrinsic Value|Tags: $NYSE:BMY, Drug Manufacturers - General, NYSE|0 Comments

Bristol Myers Squibb and 2seventy Bio to Present Abecma Label Expansion to FDA Advisory Committee
Gallery

Bristol Myers Squibb and 2seventy Bio to Present Abecma Label Expansion to FDA Advisory Committee

🌥️Trending News BRISTOL-MYERS ($NYSE:BMY): Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines [...]